Rockeby signs HK distributor

By Melissa Trudinger
Monday, 12 January, 2004

Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau.

The unique test for vaginal candidiasis (thrush) -- a disease that affects 75 per cent of women at least once in their lifetime -- will be initially marketed there as a point of care test available from general practitioners, gynaecologists and obstetricians.

It has already been launched in several other Asia-Pacific markets including Australia, New Zealand, Singapore and Malaysia.

The Singapore- and Australia-based company listed on the ASX on December 23rd at AUD$0.20 and at the time of writing was trading at $0.245.

Related News

Novel glycopeptide antibiotic candidate shows promise

Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...

Why a gluten-free diet fails in some coeliac patients

Abnormal immune cells are driving ongoing intestinal inflammation that causes symptoms like...

Giving rotavirus vaccine at birth benefits gut bacteria

Babies who receive a RV3-BB rotavirus vaccine at birth appear to show higher levels of good...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd